Effects of dietary clenbuterol and salbutamol on meat quality in veal calves.
Sixty male calves were assigned to one of four treatments, including (1) an untreated control, (2) clenbuterol; 1·6 mg/(calf.day), (3) and (4) salbutamol: 60 and 100 mg/(calf.day). Animals were milk-fed during 24 weeks, and β(2)-agonists (BA) treatment occurred during the last 4 weeks including a 3-day withdrawal period before slaughter. Under identical feed intake amongst groups, treatments with BA had significantly positive effects on carcass weights and dressing percentages. BA induced muscle hypertrophy as evidenced by an improved EUROP carcass classification, 1 19-24% higher m. longissimus loin eye area and higher muscle protein/DNA and protein/RNA ratios. Through a dilution effect, this might explain the lower haem content of the m. semimembranosus and m. longissimus lumborum (LL) and diminished Hunter a(∗) value (redness) of the latter muscle. A higher ultimate pH was found in the m. semitendinosus and m. psoas major of BA-treated calves. The m. longissimus thoracis glycogen content appeared to be lowered by salbutamol. No effects of BA were encountered for water-holding properties of this muscle. Significantly higher shear force values (31-45%) for treated animals were measured for the LL which were parallelled by higher initial values for the calpain-inhibiting activity of calpastatin and a decrease of the μ-calpain/calpastatin ratio. EUROP fatness of carcasses and LL intramuscular fat content tended to be lowered by both BA. Effects of clenbuterol and of the higher salbutamol dose, which on a molecular base was administered at a 70 times higher level, were roughly of a comparable order. The lower dose mostly had intermediate effects. This means that in veal calves, clenbuterol is biologically more potent than salbutamol.